Current evidence suggests the treatment does not improve survival or reduce the need for ventilation in COVID-19 patients, the World Health Organization says.
Ebola virus was detected in samples from a child who died last week, the World Health Organization and Democratic Republic of the Congo’s Ministry of Health announce.
In his book’s Introduction, physician-scientist Paul A. Offit reviews the unusual constellation of circumstances around the development of COVID-19 vaccines.
The organization implored nations to wait on booster shots until the global vaccination rate increases, but several of the world’s more well-off countries have expressed their intentions to offer them regardless.
The guidance comes after two years of consulting with hundreds of stakeholders, including indigenous peoples, religious leaders, patient groups, and scientists.
The certification, a major accomplishment for the world’s most populous nation, may serve as an example to other countries struggling with malaria eradication.
The World Health Organization–led program will promote equity in addition to facilitating access to samples, a WHO official involved in the project tells The Scientist.
A letter signed by 18 researchers argues that hypotheses about zoonotic spillover or accidental lab release both “remain viable” in the absence of additional evidence.
Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.
An investigation by the World Health Organization into the origins of COVID-19 will instead focus on the virus’s animal origins and the possibility of spread through frozen foods.